Prevalence of measurable residual disease in patients with refractory/relapsed multiple myeloma who reached complete response: a cross-sectional multicentric study

Prevalence of measurable residual disease in patients with refractory/relapsed multiple myeloma who reached complete response: a cross-sectional multicentric study

BackgroundMultiple myeloma (MM) is an incurable hematologic malignancy, and even though the complete response (CR) rate has been growing, a high percentage of patients continues to relapse. Recent research showed that most relapses may be related to the persistence of measurable residual disease (MR...

Full description

Bibliographic Details
Main Authors: Manuel Neves, Rita Gerivaz, Graça Esteves, Rui Bergantim, Gisela Ferreira, Henrique Coelho, Celina Afonso, Delfim Duarte, Anabela Neves, Helena Matos Silva, Joana Caetano, Rita Jaime, Catarina Geraldes, Paulo Lúcio
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Hematology
Subjects:
minimal residual disease
multiple myeloma
refractory
relapse
complete response
cross-sectional
Online Access:https://www.frontiersin.org/articles/10.3389/frhem.2024.1480120/full

Internet

https://www.frontiersin.org/articles/10.3389/frhem.2024.1480120/full

Similar Items